AR071255A1 - Derivados de sulfonatos de dioxoantraceno, composiciones farmaceuticas, uso para preparar medicamentos y metodo de preparacion de dichos derivados - Google Patents
Derivados de sulfonatos de dioxoantraceno, composiciones farmaceuticas, uso para preparar medicamentos y metodo de preparacion de dichos derivadosInfo
- Publication number
- AR071255A1 AR071255A1 ARP080104929A ARP080104929A AR071255A1 AR 071255 A1 AR071255 A1 AR 071255A1 AR P080104929 A ARP080104929 A AR P080104929A AR P080104929 A ARP080104929 A AR P080104929A AR 071255 A1 AR071255 A1 AR 071255A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- formula
- derivatives
- so3r6
- independently
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/57—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing carboxyl groups bound to the carbon skeleton
- C07C309/60—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing carboxyl groups bound to the carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
- C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
- A61K31/10—Sulfides; Sulfoxides; Sulfones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/22—Ortho- or ortho- and peri-condensed systems containing three rings containing only six-membered rings
- C07C2603/24—Anthracenes; Hydrogenated anthracenes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Reproductive Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
Abstract
Compuestos que pueden tener actividad anti-inflamatoria tienen la formula general (1): en donde R1, R2, R3 son cada uno independientemente H o un grupo alquilo C1-4 o un grupo acilo C2-4; R4 y R5 son cada uno independientemente H o un grupo de la formula -SO3R6, en donde R6 es H o un grupo alquilo C1-4 o un grupo acilo C2-4; con la condicion de que al menos uno de R4 y R5 es un grupo de la formula -SO3R6, o una sal farmacéuticamente aceptable del mismo. Reivindicacion 9: Una composicion farmacéutica que comprende un compuesto de acuerdo con una cualquiera de las reivindicaciones 1 a 3, o una sal farmacéuticamente aceptable del mismo como un ingrediente activo. Reivindicacion 13: Uso de un compuesto de acuerdo con una cualquiera de las reivindicaciones 1 a 3 para la fabricacion de un medicamento para el tratamiento de condiciones que son mediadas o influenciadas por citoquinas pro-inflamatorias de la familia de la IL-1. Reivindicacion 14: Método para la preparacion de un compuesto de la formula (1) en donde R1, R2, R3 son cada uno independientemente H o un grupo alquilo C1-4 o un grupo acilo C2-4; R4 y R5 son cada uno independientemente H o un grupo de formula -SO3R6, en donde R6 es H o un grupo alquilo C1-4 o grupo acilo C2-4; con la condicion de que al menos uno de R4 y R5 es un grupo de la formula -SO3R6 o una sal farmacéuticamente aceptable del mismo, que comprende tratar el compuesto de la formula (2) en donde R1, R2, R3 son H, con ácido sulfurico concentrado.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07022268A EP2060562A1 (en) | 2007-11-16 | 2007-11-16 | Dioxoanthracene sulphonate derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
AR071255A1 true AR071255A1 (es) | 2010-06-09 |
Family
ID=39262809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP080104929A AR071255A1 (es) | 2007-11-16 | 2008-11-12 | Derivados de sulfonatos de dioxoantraceno, composiciones farmaceuticas, uso para preparar medicamentos y metodo de preparacion de dichos derivados |
Country Status (20)
Country | Link |
---|---|
US (2) | US8754128B2 (es) |
EP (2) | EP2060562A1 (es) |
JP (1) | JP5512532B2 (es) |
KR (1) | KR101527620B1 (es) |
CN (1) | CN101861301B (es) |
AR (1) | AR071255A1 (es) |
AU (1) | AU2008322341B2 (es) |
BR (1) | BRPI0819320B1 (es) |
CA (1) | CA2704630C (es) |
CL (1) | CL2008003378A1 (es) |
CO (1) | CO6270356A2 (es) |
DK (1) | DK2220036T3 (es) |
ES (1) | ES2400028T3 (es) |
HK (1) | HK1147738A1 (es) |
MX (1) | MX2010004800A (es) |
MY (1) | MY153945A (es) |
PT (1) | PT2220036E (es) |
RU (1) | RU2482109C2 (es) |
UA (1) | UA99745C2 (es) |
WO (1) | WO2009063427A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102573873B (zh) | 2009-07-16 | 2014-10-08 | 太阳星光齿磨公司 | 蛋白多糖含有物 |
WO2012099216A1 (ja) | 2011-01-19 | 2012-07-26 | 国立大学法人弘前大学 | プロテオグリカンの大量調製法 |
SG11201500211PA (en) * | 2012-07-25 | 2015-03-30 | Univ Hirosaki | Composition for preventing or treating osteoarthritis |
CN103110617A (zh) * | 2013-03-22 | 2013-05-22 | 中国人民解放军肾脏病研究所 | 一种双醋瑞因在制备治疗糖尿病肾病药物中的用途 |
US20160252954A1 (en) * | 2015-02-27 | 2016-09-01 | Microsoft Technology Licensing, Llc | Control apparatus |
WO2017123672A1 (en) * | 2016-01-12 | 2017-07-20 | Lawrence Chan | Combination treatment for inflammatory diseases |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA761627B (en) | 1976-03-16 | 1978-01-25 | C Friedmann | Improvements in or relating to the treatment of arthritis |
GB9103075D0 (en) * | 1991-02-13 | 1991-03-27 | Washington Odur Ayuko | Trinitrobenzene derivatives and their therapeutic use |
DE4120990C2 (de) | 1991-06-25 | 1995-07-27 | Madaus Ag | Verfahren zur Herstellung von Diacetylrhein |
NZ245989A (en) * | 1992-02-28 | 1995-02-24 | Lilly Industries Ltd | Anthraquinone derivatives and pharmaceutical compositions |
IT1264545B1 (it) | 1993-07-30 | 1996-10-02 | Medidom Lab | Procedimento per la preparazione della diacereina |
FR2757397B1 (fr) * | 1996-12-23 | 1999-03-05 | Mazal Pharma | Composition pharmaceutique a base de rheine ou de diacerheine a biodisponibilite amelioree |
AR026801A1 (es) * | 2000-01-12 | 2003-02-26 | Medidom Lab | Sustancias para uso en el tratamiento de la psoriasis |
WO2002007639A1 (en) | 2000-07-24 | 2002-01-31 | Cbite, Inc. | Disposable articulator having at least one continuous opening for acceptance of stabilization means |
US6610750B1 (en) | 2000-09-15 | 2003-08-26 | Laboratoires Negma | Treatment of osteoarthritis |
US20020128317A1 (en) | 2001-01-23 | 2002-09-12 | Laboratories Negma | Treatment of pathological conditions characterized by an increased IL-1 level |
US20040198716A1 (en) * | 2001-02-05 | 2004-10-07 | Dorit Arad | Cysteine protease inhimbitors |
US6797727B2 (en) * | 2001-07-16 | 2004-09-28 | Transition Therapeutics Inc. | Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases |
RU2246485C1 (ru) * | 2003-11-04 | 2005-02-20 | Государственное образовательное учреждение высшего профессионального образования "Ивановский государственный химико-технологический университет" (ГОУВПО "ИГХТУ") | 2,3-дикарбокси-6-сульфоантрахинон |
RU2280027C1 (ru) * | 2005-03-18 | 2006-07-20 | Государственное образовательное учреждение высшего профессионального образования "Ивановский государственный химико-технологический университет" (ГОУВПО "ИГХТУ") | 2,3-дикарбокси-5,8-диметокси-6-сульфоантрахинон |
-
2007
- 2007-11-16 EP EP07022268A patent/EP2060562A1/en not_active Withdrawn
-
2008
- 2008-11-12 AR ARP080104929A patent/AR071255A1/es active IP Right Grant
- 2008-11-13 CL CL2008003378A patent/CL2008003378A1/es unknown
- 2008-11-14 AU AU2008322341A patent/AU2008322341B2/en active Active
- 2008-11-14 RU RU2010124422/04A patent/RU2482109C2/ru active
- 2008-11-14 WO PCT/IB2008/054777 patent/WO2009063427A1/en active Application Filing
- 2008-11-14 MX MX2010004800A patent/MX2010004800A/es active IP Right Grant
- 2008-11-14 BR BRPI0819320-7A patent/BRPI0819320B1/pt active IP Right Grant
- 2008-11-14 CN CN2008801161605A patent/CN101861301B/zh active Active
- 2008-11-14 UA UAA201005950A patent/UA99745C2/ru unknown
- 2008-11-14 ES ES08850100T patent/ES2400028T3/es active Active
- 2008-11-14 PT PT88501002T patent/PT2220036E/pt unknown
- 2008-11-14 DK DK08850100.2T patent/DK2220036T3/da active
- 2008-11-14 US US12/743,212 patent/US8754128B2/en active Active
- 2008-11-14 JP JP2010533705A patent/JP5512532B2/ja active Active
- 2008-11-14 KR KR1020107013225A patent/KR101527620B1/ko active IP Right Grant
- 2008-11-14 EP EP08850100A patent/EP2220036B1/en active Active
- 2008-11-14 CA CA2704630A patent/CA2704630C/en active Active
- 2008-11-14 MY MYPI2010002188A patent/MY153945A/en unknown
-
2010
- 2010-05-14 CO CO10057756A patent/CO6270356A2/es active IP Right Grant
-
2011
- 2011-02-25 HK HK11101930.8A patent/HK1147738A1/xx unknown
-
2014
- 2014-05-02 US US14/268,712 patent/US20150011636A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP5512532B2 (ja) | 2014-06-04 |
EP2060562A1 (en) | 2009-05-20 |
CA2704630A1 (en) | 2009-05-22 |
AU2008322341B2 (en) | 2013-02-21 |
US8754128B2 (en) | 2014-06-17 |
EP2220036A1 (en) | 2010-08-25 |
US20110054032A1 (en) | 2011-03-03 |
CO6270356A2 (es) | 2011-04-20 |
KR20100097162A (ko) | 2010-09-02 |
ES2400028T3 (es) | 2013-04-05 |
BRPI0819320A2 (pt) | 2020-09-08 |
HK1147738A1 (en) | 2011-08-19 |
EP2220036B1 (en) | 2012-12-26 |
MY153945A (en) | 2015-04-15 |
KR101527620B1 (ko) | 2015-06-09 |
CN101861301A (zh) | 2010-10-13 |
CL2008003378A1 (es) | 2011-04-01 |
MX2010004800A (es) | 2010-05-20 |
CN101861301B (zh) | 2013-05-29 |
WO2009063427A1 (en) | 2009-05-22 |
AU2008322341A1 (en) | 2009-05-22 |
PT2220036E (pt) | 2013-03-05 |
BRPI0819320B1 (pt) | 2021-11-09 |
CA2704630C (en) | 2016-01-19 |
RU2010124422A (ru) | 2011-12-27 |
RU2482109C2 (ru) | 2013-05-20 |
DK2220036T3 (da) | 2013-03-25 |
US20150011636A1 (en) | 2015-01-08 |
UA99745C2 (en) | 2012-09-25 |
JP2011503170A (ja) | 2011-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR069490A1 (es) | Agonistas de los receptores de glucocorticoides | |
AR053162A1 (es) | Compuesto 5 - oxo - pirrolidin sustituido, composicion farmaceutica que lo comprende y su uso para preparar un medicamento para el tratamiento del glaucoma. | |
EA201201031A1 (ru) | Ингибиторы вируса гепатита с | |
EA201171376A1 (ru) | Производные тиено[2,3-b]пиридина в качестве ингибиторов репликации вируса | |
EA202090514A1 (ru) | Противовирусное средство против гепатита в | |
CU20110216A7 (es) | Derivados aminobutíricos sustituidos como inhibidores de neprilisina | |
AR071255A1 (es) | Derivados de sulfonatos de dioxoantraceno, composiciones farmaceuticas, uso para preparar medicamentos y metodo de preparacion de dichos derivados | |
CO6470847A2 (es) | Derivados amino-propiónicos sustituidos como inhibidores de neprilisina | |
BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
UY39032A (es) | Compuestos heterocíclicos como agentes antivirales | |
BR112015016911A2 (pt) | tiadiazol, análogos dos mesmos e métodos de tratamento de condições relacionadas à deficiência de smn | |
BR112014010105A2 (pt) | aminas de c-28 de derivados de ácido betulínico modificado por c-3 como inibidores de maturação de hiv | |
MX2012007410A (es) | Compuestos antivirales novedosos. | |
AR081638A1 (es) | Amidas c-28 de derivados del acido betulinico c-3 modificados como inhibidores de la maduracion del vih | |
PE20210668A1 (es) | Analogos de carba-nucleosidos sustituidos con 2'-fluoro antivirales | |
BR112014023384A2 (pt) | inibidores de bace de di-hidro-tiazina e di-hidro-oxazina espirocíclicos, e composições e usos dos mesmos | |
BR112015019590A2 (pt) | derivados de ácido betulínico modificado com c-3 alquila e alquenila úteis no tratamento de hiv | |
DOP2012000011A (es) | Formulacion farmaceutica | |
AR108046A1 (es) | Derivados de indolina sustituidos como inhibidores de la replicación viral del dengue | |
AR072233A1 (es) | Derivados de acido lipoico y composiciones farmaceuticas que los contienen y metodos para tratar una enfermedad | |
BR112013026257A2 (pt) | derivados de glicosídeo e usos dos mesmos para o tratamento de diabetes | |
BR112015019369A2 (pt) | derivados de ácido bisfenil butanóico substituídos como inibidores de nep (endopeptidase neutra) | |
PE20121523A1 (es) | Metodo de tratamiento | |
UY33473A (es) | Compuestos y métodos para el tratamiento o la prevencion de infecciones por flavivirus | |
BR112013026361A2 (pt) | derivados de glicosídeo e usos dos mesmos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |